SEC Form 4 · accession 0001964281-26-000004
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle Quinn
Officer — EVP, GC and Secretary
Period of report
Aug 3, 2026
Accepted (ET)
Aug 4, 2026 · 7:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 3, 2026 | A | 6,346 | $0.00 | A | 26,721 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Share UnitsF2,F3,F4 | — | Aug 3, 2026 | A | 15,863 | A | — | — | Ordinary Shares | 15,863 | 15,863 | D |
| Stock Option (Right to Buy)F5 | $86.68 | Aug 3, 2026 | A | 45,070 | A | — | Aug 3, 2036 | Ordinary Shares | 45,070 | 45,070 | D |
Explanation of responses
- F1Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- F2Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- F3Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
- F4The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,863 shares will be issued. If maximum performance metrics are achieved, 38,071 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F5These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.